{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-21-013070","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2021-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.324647+00:00","generated_at":"2026-06-28T22:26:33.965866+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Brooks Automation President of Life Sciences Services Amy Liao to depart after 2021 transition","bullets":["Amy Liao steps down as President, Life Sciences Services, effective Oct 11, 2021.","Liao will serve as strategic advisor to CEO through Dec 31, 2021 at 62.5% base salary.","Liao will then leave the company to pursue other interests.","She led integration of GENEWIZ and services growth; helped prepare launch of Azenta Life Sciences."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-21-013070","json":"https://secwatch.observer/filing/0001558370-21-013070.json","markdown":"https://secwatch.observer/filing/0001558370-21-013070.md","text":"https://secwatch.observer/filing/0001558370-21-013070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000155837021013070/0001558370-21-013070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000155837021013070/brks-20211004x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T22:26:33.965866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d0b95b52ed","claim":"Guojuan (Amy) Liao departed as President, Life Sciences Services at Azenta, Inc..","evidence_excerpt":"On October 4, 2021, Brooks Automation, Inc. (“Brooks”) and Guojuan (Amy) Liao agreed that Dr. Liao will no longer serve as President, Life Sciences Services effective as of October 11, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/933974/000155837021013070/0001558370-21-013070-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"no longer serve as"},{"label":"Role","value":"President, Life Sciences Services"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}